XYNTHA SOLOFUSE

Google image searchProduct monograph

Active ingredient

moroctocog alfa, 2000 UNIT/SYR

DIN: 02374080

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE, DUAL-CHAMBER SYRINGE, PREFILLED WITH XYNTHA AND 4ML DILUENT

Schedule: Schedule D

Company: PFIZER CANADA ULC

Date: 08-MAY-2012

ATC:

Reference brand drug: Adynovate, Eloctate, Esperoct, Jivi, Kovaltry, Nuwiq, Obizur, Xyntha, Zonovate

Pharmaceutical standard: MFR

Search on Google